Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Cerus Corp (NASDAQ:CERS)

2.50
Delayed Data
As of Aug 18
 -0.02 / -0.79%
Today’s Change
1.93
Today|||52-Week Range
7.19
-42.53%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Medical Specialties
MARKET CAP
$272.8M

Company Description

Cerus Corp. engages in the research, development, and manufacture of biomedical and surgical products. It produces blood system for platelets and plasma. It markets its products under the INTERCEPT brand. The company was founded by Laurence M. Corash and John E. Hearst on September 19, 1991 and is headquartered in Concord, CA.

Contact Information

Cerus Corp.
2550 Stanwell Drive
Concord California 94520
P:(925) 288-6000
Investor Relations:
(925) 288-6319

Employees

Shareholders

Individual stakeholders4.97%
Other institutional34.95%
Mutual fund holders28.98%

Top Executives

William Mariner GreenmanPresident, Chief Executive Officer & Director
Suzanne MargerumVice President-Manufacturing & Operations
Kevin Dennis GreenChief Financial Officer & Vice President-Finance
Laurence M. CorashDirector & Chief Scientific Officer
Richard J. BenjaminChief Medical Officer